Clinical Update 1, 2014 - Deborah Heart and Lung Center

UPDATE
Clinical
Issue 1, 2014
DEBORAH Heart and Lung Center
®
CTO
“These new devices and techniques require an extraordinary
amount of training and skill. Chronic
total occlusions previously had limited
treatment alternatives beyond medical
management or surgery, and we are thrilled to
finally have a new approach for treating this condition.”
--Richard Kovach, MD,
Chair, Interventional Cardiology and
Medical Director of the Catheterization Laboratory
Inside this issue you will find:
•
•
•
•
Hybrid OR Procedures
CTO Program
Hyperbaric Oxygen Therapy
Bariatrics at Deborah
Hybrid OR Procedures
D
valve replacement, carotid stenting, subclavian angioplasty,
eborah recently opened its state-of-the-art
endovascular repair of thoracic aortic aneurysms,
Hybrid Operating Room. The new 1,000-squareendovascular repair of abdominal aortic aneurysms,
foot $4 million Hybrid OR features a 3-station
mesenteric angioplasty and stenting, renal artery angiocomputer system for continuous monitoring of a patient’s
hemodynamics. Real-time imaging is delivered through the plasty and stenting, complex hybrid peripheral vascular
revascularization procedures, ASD closure, VSD repairs,
robotic Siemens Artis zeego® multi-axis angiography
system which permits integration
with retrospective scans to drive
“A distinct advantage for patients in the Hybrid OR is
extensive data analysis, increasing
greatly reduced patient recovery time. Additionally,
both the precision and safety of
patients who formerly would have to undergo two
complex cardiovascular
separate procedures for bypass surgery and stenting
interventions.
now are afforded an opportunity to receive both at
The operations performed at the
Lynn B. McGrath, MD
once with hybrid coronary revascularization. This
hospital represent collaboration
Vice President
approach reduces hospitalization time. From many
among Deborah’s skilled cardiac surMedical Affairs,
perspectives the new Hybrid OR is a win-win
gical staff, vascular surgeons and
Chair, Department
situation.”
of Surgery
interventional cardiologists working
side-by-side in one operating suite
hybrid PCI/CABG procedures, atrial appendage closure,
for blended procedures which combine multiple disciplines. With a full surgical and interventional team, joined and other complex repairs. Patients who are considered for
Hybrid OR procedures will be thoroughly evaluated for
with echocardiography and anesthesia professionals, the
new Hybrid OR offers minimally-invasive approaches to
suitability, based on strict clinical criteria, including exclusion from other surgical or interventional options and must
challenging cardiovascular procedures.
A variety of procedures will be performed in the new
meet inclusionary criteria for hybrid procedures.™
Hybrid OR, including transcatheter and transapical aortic
DEBORAH® HEART AND LUNG CENTER
Patient Referral: 1-800-214-3452
CTO Program
T
echnologic advances for treating 100% chronically
occluded coronary arteries is enabling numerous
Deborah patients to avoid open heart bypass
surgery, and have given them a new lease on life. Deborah’s
Chronic Total Coronary Occlusion (CTO) Program uses
novel tools and techniques to approach CTOs and is
achieving significant procedural success rates in crossing
and opening these complex lesions.
In conjunction with new technologies from Boston
Scientific and other manufacturers–such as the CrossBoss™
and Stingray™ Coronary CTO Crossing and Re-entry System,
the only FDA-cleared devices for use in CTOs–Deborah’s
Program offers a fresh approach to these complex cases,
especially for those considered too risky for bypass operations or with anatomy not technically amenable to bypass
surgery, and for those others whose surgical bypass grafts
have also become occluded.
With these new technologies in place, along with Deborah’s
specialists’ rigorous training in the techniques required to use
these technologies, the hospital’s interventional cardiologists
are now able to create a new pathway for the treatment of
completely blocked arteries. These new devices are able to
either move directly through the occlusion, or–if the blockage is too hard–to go around the blockage by entering the
deeper layers of the arterial wall, using additional technology
to reenter the open blood vessel beyond the blockage, thus
creating a successful avenue for blood to flow around the
blockages. Alternatively, these 100% blockages can be
crossed in reverse by advancing special wires and devices
through collateral channels arising from other open vessels
that connect with the totally blocked artery.™
Richard
Kovach, MD
Jon
George, MD
Kintur
Sanghvi, MD
Vincent
Varghese, DO
Hyperbaric Oxygen Therapy
D
eborah has opened The James Klinghoffer
Center for Wound Healing and Hyperbaric
Treatment. The new wound care center features
hyperbaric oxygen (HBOt) chambers delivering 100% pure
oxygen in a pressurized environment two to three times
higher than normal air pressure, enabling quicker resolution for non-healing wounds. The program offers a comprehensive approach from Deborah specialists to care for
patients with non-healing wounds and complex medical
issues, in partnership with a strong panel of board certiremain inside the state-of-the-art chamber–equipped with
TV and ease of communication– from one to two hours,
fied wound and hyperbaric specialists. The new Center
provides a natural extension for Deborah’s core specialty
usually every other day, until the healing is complete.™
services, and additional
“There are many slow-healing chronic wounds including
continuum of care, since
venous leg ulcers, arterial insufficiency, diabetic foot ulcers,
many cardiovascular
bed sores, burns and spider bites. Our wound therapy team is
patients suffer with poor
experienced in standard treatments like debridement,
circulation and diabetes,
advanced dressing, compression therapy and nutritional
often leading to slow-healsupport. When these therapies alone are not enough, the new
ing wounds, especially on
John Cooper, DO,
hyperbaric chambers will provide an extremely valuable tool,
the lower extremities.
FACOS,
working in tandem with other advanced therapies available at
Patients who use the
Medical Director
Deborah such as transluminal angioplasty and stenting, laser
Wound Care Center
hyperbaric chambers for
atherectomy,
venous
ablation
and
skin
substitutes.”
oxygen therapy enter and
DEBORAH® HEART AND LUNG CENTER
Patient Referral: 1-800-214-3452
DEBORAH® Heart and Lung Center
200 Trenton Road
Browns Mills, NJ 08015
Clinical UPDATE
published by
Deborah Heart and Lung Center, Browns Mills, NJ 08015
Joseph P. Chirichella, President and CEO
Lynn B. McGrath, MD, Vice President, Medical Affairs
Thomas J. Campbell III, Director, Marketing and PR, Editor;
Donna McArdle, Writer; June Lambert, Coordinator;
Susanna Kanzler, Proofreader; Frances Marshall, Layout/Design;
Barbara Minnick, Cover Design; Agnes Marsala, Photography
Jon George, MD,
Director, Clinical
Research and
Assistant Director,
Cardiac Catheterization Laboratory,
Deborah Heart and Lung
Center recently had a
book published by Nova
Science Publishers.
For registration information on this symposium go to
www.deborah.org
Bariatrics at DEBORAH
D
Patients whose Body Mass Index (BMI) -- relationship
eborah is pleased to announce its new Bariatric
Program for patients suffering with morbid
of height to weight -- is greater than 40 are candidates for
bariatric surgery. Patients whose BMI is between 35-39.9
obesity and its associated conditions including:
diabetes, high blood pressure, sleep apnea, and degenerawith other serious health complications such as Type II
tive joint disease. These patients will benefit from the
Diabetes, high blood pressure, or sleep apnea, are also
suitable candidates for weight loss surgery.
hospital’s new partnership with surgical weight loss
experts from Garden State Bariatrics
and Wellness Center.
“The majority of obese patients with diabetes who
The hospital now features a
undergo gastric bypass, experience not only significant
comprehensive on-site bariatric
weight loss, but the possibility of diabetes remission
program offering patients gastric
as well. New research suggests these patients may also
bypass, gastric sleeve and duodenal
cut their risk of heart attack by 40% and their risk of
switch surgical procedures, as part
stroke by 42% over a 10-year time period.”*
Michael Bilof, MD
of an overall program focusing on
Medical Director
nutrition, healthy living, and
*(as reported during Obesity Week 2013, Atlanta, GA)
Bariatric Program
exercise.
DEBORAH® HEART AND LUNG CENTER
Patient Referral: 1-800-214-3452

Download Report